abstract |
Novel peptides are provided for use in diagnosing CagA + Helicobacter pylori infection or in predicting risk for gastric cancer. The peptide binds to an antibody derived from a patient of CagA + Helicobacter pylori with high specificity and high sensitivity, and can be used, for example, in a diagnostic kit. [Selection diagram] Fig. 3 |